2.31
-0.135(-5.52%)
Currency In USD
| Previous Close | 2.44 |
| Open | 2.34 |
| Day High | 2.38 |
| Day Low | 2.31 |
| 52-Week High | 9.79 |
| 52-Week Low | 0.97 |
| Volume | 128,665 |
| Average Volume | 794,642 |
| Market Cap | 11.08M |
| PE | -0.26 |
| EPS | -9.02 |
| Moving Average 50 Days | 2.15 |
| Moving Average 200 Days | 2.25 |
| Change | -0.14 |
If you invested $1000 in Phio Pharmaceuticals Corp. (PHIO) 10 years ago, it would be worth $0.01 as of July 12, 2025 at a share price of $2.31. Whereas If you bought $1000 worth of Phio Pharmaceuticals Corp. (PHIO) shares 5 years ago, it would be worth $9.22 as of July 12, 2025 at a share price of $2.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort
Newsfile
Jun 25, 2025 11:45 AM GMT
-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in fourth cohort, permitting dose escalation in expected final cohortMarlborough, Massachusetts--(Newsfile Corp. - June 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ:
Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio
Newsfile
Jun 06, 2025 11:45 AM GMT
- Robert Infarinato named VP, Strategic Development- Lisa Carson named as new VP, Finance and AdministrationMarlborough, Massachusetts--(Newsfile Corp. - June 6, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceu
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference
Newsfile
May 19, 2025 11:45 AM GMT
Registration Link for Presentation to take place Thursday, May 22, 2025 at 10:00 AM ETMarlborough, Massachusetts--(Newsfile Corp. - May 19, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developi